S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
California bill to have human drivers ride in autonomous trucks is vetoed by governor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
California bill to have human drivers ride in autonomous trucks is vetoed by governor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
California bill to have human drivers ride in autonomous trucks is vetoed by governor
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
A 73-Year-Old Market Signal With 95% Accuracy Just Flashed (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
New AI Stock Payouts (Ad)
Speaker McCarthy is giving hard-right Republicans what they want. But it never seems to be enough.
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
California bill to have human drivers ride in autonomous trucks is vetoed by governor
LON:AVCT

Avacta Group (AVCT) Share Forecast, Price & News

GBX 129
+1.00 (+0.78%)
(As of 09/22/2023 ET)
Compare
Today's Range
126.25
133.45
50-Day Range
92
130
52-Week Range
87.99
187.98
Volume
1.67 million shs
Average Volume
1.54 million shs
Market Capitalization
£360.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

AVCT stock logo

About Avacta Group (LON:AVCT) Stock

Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms. The company develops AVA6000, FAPa-activated doxorubicin that is in Phase I clinical trial for treating locally advanced or metastatic-selected solid tumors; AVA3996, a tumor-targeted proteasome inhibitor based on bortezomib; AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing LR19128 PD-L1 XT; and collaboration and license agreement with Avacta and Daewoong Pharmaceutical Co. Ltd. for developing AFX-001 for solid organ transplant and graft vs host Disease, and AFX-002 for multiple sclerosis. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.

AVCT Price History

AVCT Stock News Headlines

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Avacta Group Share Chat
He's Giving Away His Ultimate Dividend Package FOR FREE!
Marc Lichtenfeld, Author of Get Rich with Dividends, is giving away his Ultimate Dividend Package, Including Details on His #1 Dividend Stock... the Safest 8% Dividend in the World... the Top Three "Extreme Dividend" Stocks... and Much, Much More. For Free.
AVCT.L - Avacta Group Plc
Block Listing Application to AIM
Avacta Group Plc (AVCT.L)
LG Chem Renews License Triggering Payment to Avacta
Avacta full-year results push shares higher
What’s next for the Avacta share price?
See More Headlines
Receive AVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter.

AVCT Company Calendar

Last Earnings
9/28/2020
Today
9/24/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Net Income
£-39,540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.65 million
Cash Flow
GBX 8.60 per share
Book Value
GBX 7 per share

Miscellaneous

Free Float
N/A
Market Cap
£360.32 million
Optionable
Not Optionable
Beta
1.46
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. David Alastair Maclaughlin Smith (Age 57)
    CEO & Exec. Director
    Comp: $444k
  • Mr. Tony Gardiner (Age 52)
    CFO, Company Sec. & Exec. Director
    Comp: $273k
  • Ms. Emma Wright
    Group In-House Counsel
  • Mr. Michael Vinegrad
    Group Communications Director
  • Mr. Craig Slater (Age 60)
    Chief Operating Officer of Diagnostics
  • Dr. Matt Johnson
    Chief Scientific Officer of Diagnostics
  • Dr. Neil Bell (Age 65)
    Chief Devel. Officer of Therapeutics
  • Dr. Fiona McLaughlin FSB (Age 53)
    Ph.D., Chief Scientific Officer of Therapeutics Division
  • Mr. David Wilson
    Chief Commercial Officer of Diagnostics
  • Ms. Karen Harrison
    Chief Operating Officer of Therapeutics Division













AVCT Stock - Frequently Asked Questions

How have AVCT shares performed in 2023?

Avacta Group's stock was trading at GBX 115 at the beginning of 2023. Since then, AVCT shares have increased by 12.2% and is now trading at GBX 129.
View the best growth stocks for 2023 here
.

How were Avacta Group's earnings last quarter?

Avacta Group Plc (LON:AVCT) issued its quarterly earnings results on Monday, September, 28th. The biotechnology company reported ($3.74) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Avacta Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avacta Group investors own include Legal & General Group (LGEN), SkinBioTherapeutics (SBTX), Augean (AUG), 7digital Group (7DIG), American Airlines Group (AAL), ACI Worldwide (ACIW), Akero Therapeutics (AKRO), Advanced Micro Devices (AMD) and Amyris (AMRS).

What is Avacta Group's stock symbol?

Avacta Group trades on the London Stock Exchange (LON) under the ticker symbol "AVCT."

How do I buy shares of Avacta Group?

Shares of AVCT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Avacta Group's stock price today?

One share of AVCT stock can currently be purchased for approximately GBX 129.

How much money does Avacta Group make?

Avacta Group (LON:AVCT) has a market capitalization of £360.32 million and generates £9.65 million in revenue each year. The biotechnology company earns £-39,540,000.00 in net income (profit) each year or GBX (0.14) on an earnings per share basis.

How many employees does Avacta Group have?

The company employs 120 workers across the globe.

How can I contact Avacta Group?

Avacta Group's mailing address is Unit 20, Ash Way, WETHERBY, LS23 7FA, United Kingdom. The official website for the company is www.avacta.com. The biotechnology company can be reached via phone at +44-1904-217070.

This page (LON:AVCT) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -